BIOMECHANICAL ASSESSMENT OF UPRIGHT STANCE IN PARKINSONS-DISEASE - A SINGLE-SUBJECT STUDY

被引:20
作者
PANZER, VP
HALLETT, M
机构
[1] National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD
基金
美国国家卫生研究院;
关键词
biomechanics; Parkinson's disease; posturography; upright stance;
D O I
10.1016/0268-0033(90)90041-4
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In order to evaluate the usefulness of biomechanical measures in the clinical assessment of Parkinson's disease, we studied the kinematics of upright stance in a patient with evident fluctuations in clinical state (ON-OFF), which allowed us to optimize experimental control. We determined the total amount of movement and the variability of whole body and body segment kinematics in the vertical, anterior-posterior (A-P), and medial-lateral planes. The total excursion parameter (TEX) represented the co-ordinate path over a 20 s period, and the movement variability parameter (VAR) was calculated based on the standard deviation about the quadratic fit to this path. Discriminant analysis was employed to assess the ability of these parameters to discriminate the patient's clinical state, and statistical reduction of the number of measures was accomplished with a stepwise selection procedure. Measures of shoulder A-P movement and the vertical motion of the centre of gravity (COG) were selected for inclusion in both discriminant functions. The VAR function included only four measures (vertical COG and A-P head, shoulder, and hip), while the TEX function required six measures to discriminate the clinical state. Results obtained with the VAR function were superior to those obtained with TEX, and VAR discriminated the OFF state, a common characteristic of Parkinson's disease, especially well. The results are promising, as the measures appear sensitive to the patient's clinical state even though fluctuation of symptoms was reduced in the latter part of the study by various treatments. © 1990.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 24 条
[1]  
Barbeau, Mars, Gillo-Jeffroy, Adverse clinical side effects of levodopa therapy, Recent Advances in Parkinson's Disease, pp. 204-237, (1971)
[2]  
Alba, Trainor, Ritter, Dasco, A clinical disability rating for Parkinson patients, J Chron Dis, 21, pp. 507-522, (1968)
[3]  
Fahn, Elton, members of the UPDRS Development Committee, Unified Parkinson's disease rating scale, Recent Developments in Parkinson's Disease, 2, pp. 153-163, (1987)
[4]  
Hoehn, Yahr, Parkinsonism: onset, progression and mortality, Neurology, 17, pp. 427-432, (1967)
[5]  
Schwab, England, Projection technique for evaluating surgery in Parkinson's disease, Third Symposium on Parkinson's Disease, pp. 152-157, (1969)
[6]  
Bianchine, Schwartz, Richard, The clinical evaluation of drug therapy in parkinsonism and models of dysfunction of brain dopamine systems in animals, Movement Disorders, pp. 103-115, (1986)
[7]  
Knutsson, An analysis of parkinsonian gait, Brain, 95, pp. 475-486, (1972)
[8]  
Sanes, Colburn, Morgan, Behavioral motor evaluation for neurotoxicity screening, Neurobehav Toxicol Teratol, 7, pp. 329-337, (1985)
[9]  
Ward, Sanes, Dambrosia, Calne, Methods for evaluating treatment in Parkinson's disease, Experimental Therapeutics of Movement Disorders Advances in Neurology, 37, pp. 1-7, (1983)
[10]  
Brand, Can biomechanics contribute to clinical orthopaedic assessment?, Abstracts, Proceedings of the XIth International Congress of the International Society of Biomechanics, (1987)